Maternal group B Streptococcus colonization: Correlation between IL-6/IL-15 cytokine profiles and infection biomarkers for early risk prediction
DOI:
https://doi.org/10.24079/CAJMS.2026.01.002Keywords:
Streptococcus agalactiae, Pregnancy Outcome, Interleukin-6, Biomarkers, Pregnancy ComplicationsAbstract
Objective: To investigate the risk factors for adverse pregnancy outcomes in women with late-trimester Group B Streptococcus (GBS) colonization and to evaluate the predictive value of serum C-reactive protein (CRP), procalcitonin (PCT), interleukin-6 (IL-6), and interleukin-15 (IL-15) as biomarkers for these outcomes. Methods: This is a prospective cohort study of 160 women (80 GBS-positive and 80 GBS-negative). Clinical data, serum biomarkers (CRP, PCT, IL-6, IL-15), and vaginal secretion samples were collected. Statistical analyses were performed to identify independent risk factors and to assess the diagnostic accuracy of the biomarkers using receiver operating characteristic (ROC) curves. Results: Independent risk factors for adverse pregnancy outcomes in GBS-colonized women include advanced maternal age, gestational diabetes mellitus, a history of miscarriage, and vaginal dysbiosis. The combined measurement of CRP, PCT, IL-6, and IL-15 showed superior predictive value for adverse pregnancy outcomes (AUC = 0.913; 95% CI, 0.85-0.97) compared to individual markers. GBS-positive women exhibited a higher incidence of co-infections and adverse neonatal outcomes, such as pneumonia and asphyxia. Conclusion: TA combination of inflammatory biomarkers can serve as a strong predictor of adverse pregnancy outcomes in women with late-stage GBS colonization. These findings support incorporating biomarker testing into GBS screening protocols to enhance risk assessment and guide clinical management.
Downloads
50
References
1. Verani JR, McGee L, Schrag SJ, et al. Prevention of perinatal group B streptococcal disease revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1-36.
2. Schrag SJ, Farley MM, Petit S, et al. Epidemiology of invasive early-onset neonatal sepsis, 2005 to 2014. Pediatrics. 2016;138:e20162013. https://doi.org/10.1542/peds.2016-2013
3. Le Doare K, O'Driscoll M, Turner K, et al. Intrapartum antibiotic chemoprophylaxis policies for the prevention of group B streptococcal disease worldwide: systematic review. Clin Infect Dis. 2017;65(suppl 2):S143-S151. https://doi.org/10.1093/cid/cix654
4. Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2011;108:4680-4687. https://doi.org/10.1073/pnas.1002611107
5. Romero R, Hassan SS, Gajer P, et al. The composition and stability of the vaginal microbiota of normal pregnant women are different from those of non-pregnant women. Microbiome. 2014;2:4. https://doi.org/10.1186/2049-2618-2-4
6. Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev. 2014;(6):CD007467. https://doi.org/10.1002/14651858.cd007467.pub4
7. Arsenijević VA, Gerginić V, Miličić B, et al. Screening of group B Streptococcus in pregnancy: a systematic review for the laboratory detection. Open Med (Wars). 2025;20:20251197. https://doi.org/10.1515/med-2025-1197
8. Kothary V, Doster RS, Rogers LM, et al. Group B Streptococcus induces neutrophil recruitment to gestational tissues and elaboration of extracellular traps and nutritional immunity. Front Cell Infect Microbiol. 2017;7:19. https://doi.org/10.3389/fcimb.2017.00019
9. Whidbey C, Harrell MI, Burnside K, et al. A hemolytic pigment of Group B Streptococcus allows bacterial penetration of human placenta. J Exp Med. 2013;210:1265-1281. https://doi.org/10.1084/jem.20122753
10. Popowski T, Goffinet F, Maillard F, et al. Maternal markers for detecting early-onset neonatal infection and chorioamnionitis in cases of premature rupture of membranes at or after 34 weeks of gestation: a two-center prospective study. BMC Pregnancy Childbirth. 2011;11:26. https://doi.org/10.1186/1471-2393-11-26
11. Romero R, Gomez R, Ghezzi F, et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol. 1998;179:186-193. https://doi.org/10.1016/s0002-9378(98)70271-6
12. Gordon SM. Interleukin-15 in outcomes of pregnancy. Int J Mol Sci. 2021;22:11094. https://doi.org/10.3390/ijms222011094
13. Menon R, Taylor RN, Fortunato SJ. Chorioamnionitis--a complex pathophysiologic syndrome. Placenta. 2010;31:113-120. https://doi.org/10.1016/j.placenta.2009.11.012
14. Gotsch F, Romero R, Kusanovic JP, et al. The fetal inflammatory response syndrome. Clin Obstet Gynecol. 2007;50:652-683. https://doi.org/10.1097/grf.0b013e31811ebef6
15. Kurian NK, Modi D. Mechanisms of group B Streptococcus-mediated preterm birth: lessons learnt from animal models. Reprod Fertil. 2022;3(3):R109-R120. https://doi.org/10.1530/raf-21-0105
16. Surve MV, Anil A, Kamath KG, et al. Membrane Vesicles of Group B Streptococcus Disrupt Feto-Maternal Barrier Leading to Preterm Birth. PLoS Pathog. 2016;12(9):e1005816. https://doi.org/10.1371/journal.ppat.1005816
17. Trochez-Martinez RD, Smith P, Lamont RF. Use of C-reactive protein as a predictor of chorioamnionitis in preterm prelabour rupture of membranes: a systematic review. BJOG. 2007;114:796-801. https://doi.org/10.1111/j.1471-0528.2007.01385.x
18. Torbé A. Maternal plasma procalcitonin concentrations in pregnancy complicated by preterm premature rupture of membranes. Mediators Inflamm. 2007;2007:35782. https://doi.org/10.1155/2007/35782
19. Sanjaya INH, Pangkahila ES, Tunas K, et al. The relationship between group B Streptococcus infection in the vagina and C-reactive protein and procalcitonin levels in pregnant women with preterm premature rupture of membranes. Eur J Med Health Sci. 2025;7(3):74-78. https://doi.org/10.24018/ejmed.2025.7.3.2306
20. Thornburg LL, Queenan R, Brandt-Griffith B, et al. Procalcitonin for prediction of chorioamnionitis in preterm premature rupture of membranes. J Matern Fetal Neonatal Med. 2016;29(13):2056-2061. https://doi.org/10.3109/14767058.2015.1077224
21. Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth. Lancet. 2008;371:75-84. https://doi.org/10.1016/s0140-6736(08)60074-4
22. Bianchi-Jassir F, Seale AC, Kohli-Lynch M, et al. Preterm birth associated with group B Streptococcus maternal colonization worldwide: systematic review and meta-analyses. Clin Infect Dis. 2017;65(suppl 2): S133-S142. https://doi.org/10.1093/cid/cix661
23. Yu W, Sun M, Li R, et al. Unveiling the microbial shift: the impact of group B Streptococcus on vaginal microbiota and inflammation in late pregnancy. BMC Microbiol. 2025;25(1):640. https://doi.org/10.1186/s12866-025-04387-5
24. 24. Rosen GH, RandisTM, Desai PV, et al. Group B Streptococcus and the Vaginal Microbiota. J Infect Dis. 2017;216(6):744-751. https://doi.org/10.1093/infdis/jix395
25. Valkenburg-van den Berg AW, Houtman-Roelofsen RL, Oostvogel PM, et al. Timing of group B streptococcus screening in pregnancy: a systematic review. Gynecol Obstet Invest. 2010;69(3):174-183. https://doi.org/10.1159/000265942
26. Kwatra G, Cunnington MC, Merrall E, et al. Prevalence of maternal colonisation with group B Streptococcus: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16:1076-1084. https://doi.org/10.1016/s1473-3099(16)30055-x
27. Stephens K, Charnock-Jones DS, Smith GCS, et al. Group B Streptococcus and the risk of perinatal morbidity and mortality following term labor. Am J Obstet Gynecol. 2023;228(5S):S1305-S1312. https://doi.org/10.1016/j.ajog.2022.07.051
28. Procter SR, Gonçalves BP, Paul P, et al. Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness. .2023;20(3):e1004068. https://doi.org/10.1371/journal.pmed.1004068
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Mongolian National University of Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
